当前位置:首页 - 行情中心 - 盟科药业-U(688373) - 财务分析

盟科药业-U

(688373)

  

流通市值:17.84亿  总市值:33.68亿
流通股本:3.47亿   总股本:6.55亿

盟科药业-U(688373)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-1.02亿元,每股收益-0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益74181.02万元,未分配利润-146610.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产110318.50万元,负债36137.48万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入33,016,131.5690,776,385.2468,272,315.4342,110,171.77
营业总成本140,526,292.61538,482,151.17335,652,567.97184,852,221.21
营业利润-102,130,819.86-410,903,822.04-240,222,918.04-120,938,665.27
利润总额-102,136,623.67-415,153,158.25-244,453,007.24-125,117,073.5
净利润-102,136,623.67-421,124,452.65-244,458,619.1-125,122,616.8
其他综合收益673,642.433,714,041.6510,842,714.3912,150,057.27
综合收益总额-101,462,981.24-417,410,411-233,615,904.71-112,972,559.53
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计992,871,282.961,054,254,994.371,163,559,404.991,257,556,081.99
非流动资产合计110,313,711.58114,309,959.18117,272,514.6121,392,594.42
资产总计1,103,184,994.541,168,564,953.551,280,831,919.591,378,948,676.41
流动负债合计137,975,631.81136,647,942.7766,190,959.6967,527,791.29
非流动负债合计223,399,200.35197,913,818207,203,028.62192,641,297.65
负债合计361,374,832.16334,561,760.77273,393,988.31260,169,088.94
归属于母公司股东权益合计741,810,162.38834,003,192.781,007,437,931.281,118,779,587.47
股东权益合计741,810,162.38834,003,192.781,007,437,931.281,118,779,587.47
负债和股东权益合计1,103,184,994.541,168,564,953.551,280,831,919.591,378,948,676.41
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计33,600,922.07108,092,882.7586,057,204.4555,016,463.16
经营活动现金流出小计134,333,713.86437,174,834.09310,838,619.02186,720,422.85
经营活动产生的现金流量净额-100,732,791.79-329,081,951.34-224,781,414.57-131,703,959.69
投资活动现金流入小计646,070,755.083,921,634,784.93,002,899,520.592,093,186,457.84
投资活动现金流出小计488,237,950.993,587,001,708.462,739,764,351.761,803,837,870.69
投资活动产生的现金流量净额157,832,804.09334,633,076.44263,135,168.83289,348,587.15
筹资活动现金流入小计30,000,00060,000,00060,000,00040,000,000
筹资活动现金流出小计6,942,436.0579,606,595.3468,381,107.6262,670,472.07
筹资活动产生的现金流量净额23,057,563.95-19,606,595.34-8,381,107.62-22,670,472.07
汇率变动对现金及现金等价物的影响-972,581.97445,282.86-1,903,406.97290,768.46
现金及现金等价物净增加额79,184,994.28-13,610,187.3828,069,239.67135,264,923.85
期末现金及现金等价物余额216,661,647.43137,476,653.15179,156,080.2286,351,764.38
最新报告期:2024-04-06
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
西南证券杜向阳-0.90-0.60-0.762024-04-06
中金公司屈潇逸-0.68-0.71--2024-03-31
TOP↑